UA43378C2 - Композиція для лікування респіраторного дистрес-синдрому новонароджених та респіраторного дистрес-синдрому дорослих - Google Patents

Композиція для лікування респіраторного дистрес-синдрому новонароджених та респіраторного дистрес-синдрому дорослих

Info

Publication number
UA43378C2
UA43378C2 UA97042034A UA97042034A UA43378C2 UA 43378 C2 UA43378 C2 UA 43378C2 UA 97042034 A UA97042034 A UA 97042034A UA 97042034 A UA97042034 A UA 97042034A UA 43378 C2 UA43378 C2 UA 43378C2
Authority
UA
Ukraine
Prior art keywords
syndrome
respiratory distress
newborns
treating
composition
Prior art date
Application number
UA97042034A
Other languages
English (en)
Russian (ru)
Inventor
Пауль-Георг ГЕРМАНН
Клаус Айстеттер
Ульріх КІЛІАН
Ульрих Килиан
Дітріх ХЕФНЄР
Дитрих Хефнер
Original Assignee
Бик Гульден Ломберг Хеміше Фабрік Гмбх
Бик Гульден Ломберг Хемише Фабрик ГмбХ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Бик Гульден Ломберг Хеміше Фабрік Гмбх, Бик Гульден Ломберг Хемише Фабрик ГмбХ filed Critical Бик Гульден Ломберг Хеміше Фабрік Гмбх
Publication of UA43378C2 publication Critical patent/UA43378C2/uk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/42—Respiratory system, e.g. lungs, bronchi or lung cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids

Abstract

Композиція для лікування респіраторного дистрес-синдрому новонароджених і респіраторного дистрес-синдрому дорослих містить як глюкокортикостероїди бетаметазон, будесоніт, метилпреднізолон, дексаметазон та/або циклосонід.
UA97042034A 1994-09-28 1995-09-27 Композиція для лікування респіраторного дистрес-синдрому новонароджених та респіраторного дистрес-синдрому дорослих UA43378C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4434629A DE4434629C1 (de) 1994-09-28 1994-09-28 Zusammensetzungen zur Behandlung von IRDS und ARDS
PCT/EP1995/003816 WO1996009831A2 (de) 1994-09-28 1995-09-27 Zusammensetzungen zur behandlung von irds und ards, die mindestens ein glucocorticosteroid in kombination mit einem lungen surfactant enthalten

Publications (1)

Publication Number Publication Date
UA43378C2 true UA43378C2 (uk) 2001-12-17

Family

ID=6529394

Family Applications (1)

Application Number Title Priority Date Filing Date
UA97042034A UA43378C2 (uk) 1994-09-28 1995-09-27 Композиція для лікування респіраторного дистрес-синдрому новонароджених та респіраторного дистрес-синдрому дорослих

Country Status (26)

Country Link
US (1) US5891844A (uk)
EP (1) EP0783314B1 (uk)
JP (1) JP4425991B2 (uk)
KR (1) KR100365030B1 (uk)
CN (1) CN1100542C (uk)
AT (1) ATE241372T1 (uk)
AU (1) AU705099B2 (uk)
BG (1) BG62556B1 (uk)
CA (1) CA2201377C (uk)
CZ (1) CZ292846B6 (uk)
DE (2) DE4434629C1 (uk)
DK (1) DK0783314T3 (uk)
EE (1) EE03422B1 (uk)
ES (1) ES2201120T3 (uk)
FI (1) FI118886B (uk)
HK (1) HK1003869A1 (uk)
HU (1) HU226958B1 (uk)
MX (1) MX9702303A (uk)
NO (1) NO313405B1 (uk)
NZ (1) NZ294587A (uk)
PL (1) PL187496B1 (uk)
PT (1) PT783314E (uk)
RU (1) RU2157222C2 (uk)
SK (1) SK284446B6 (uk)
UA (1) UA43378C2 (uk)
WO (1) WO1996009831A2 (uk)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6039932A (en) * 1996-09-27 2000-03-21 3M Innovative Properties Company Medicinal inhalation aerosol formulations containing budesonide
CN1123345C (zh) * 1997-02-17 2003-10-08 奥坦纳医药公司 治疗ards或irds的组合物
US7122344B2 (en) 1997-05-28 2006-10-17 Claragen, Inc. Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions
US20060281681A1 (en) 1997-05-28 2006-12-14 Pilon Aprile L Methods and compositions for the reduction of neutrophil influx and for the treatment of bronchpulmonary dysplasia, respiratory distress syndrome, chronic lung disease, pulmonary fibrosis, asthma and chronic obstructive pulmonary disease
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US6946117B1 (en) * 1997-09-29 2005-09-20 Nektar Therapeutics Stabilized preparations for use in nebulizers
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US20020017295A1 (en) * 2000-07-07 2002-02-14 Weers Jeffry G. Phospholipid-based powders for inhalation
US6433040B1 (en) * 1997-09-29 2002-08-13 Inhale Therapeutic Systems, Inc. Stabilized bioactive preparations and methods of use
CN1194833A (zh) * 1997-10-08 1998-10-07 刘柏宏 肺活素
US6858223B2 (en) 1998-06-23 2005-02-22 Altana Pharma Ag Compositions comprising phenylaminothiophenacetic acid derivatives for the treatment of acute or adult respiratory distress syndrome (ARDS) and infant respiratory distress syndrome (IRDS)
AU5400000A (en) * 1999-06-11 2001-01-02 Byk Gulden Lomberg Chemische Fabrik Gmbh Pharmaceutical preparation containing modifications of surfactant protein b (sp-b) and surfactant protein c (sp-c)
AU6083899A (en) * 1999-09-16 2001-04-17 Aventis Behring Gmbh Combination of c1-inh and lung surfactant for the treatment of respiratory disorders
DE19957898A1 (de) * 1999-12-01 2001-06-07 Byk Gulden Lomberg Chem Fab Neue Verwendung von Lungensurfactant
DE10018022A1 (de) * 2000-04-12 2001-10-31 Byk Gulden Lomberg Chem Fab Neue Verwendung von Lungensurfactant zur Prophylaxe oder Frühbehandlung von akuten Lungenerkrankungen
CA2405811C (en) * 2000-04-12 2011-09-27 Altana Pharma Ag Novel use of pulmonary surfactant for the prophylaxis or early treatment of acute pulmonary diseases
US20040254112A1 (en) * 2000-04-12 2004-12-16 Dietrich Hafner Use of pulmonary surfactant for the early treatment of acute pulmonary diseases
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
AU6124601A (en) * 2000-05-10 2001-11-20 Alliance Pharmaceutical Corporation Phospholipid-based powders for drug delivery
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
DE10132307A1 (de) * 2001-07-06 2003-01-30 Aventis Behring Gmbh Arzneizubereitung zur Inhalation von Antithrombin bei entzündlichen Lungenerkrankungen und ARDS
US20030099601A1 (en) * 2001-11-27 2003-05-29 Gordon Marc S. Inhalation lung surfactant therapy
WO2003053455A1 (en) * 2001-12-12 2003-07-03 Penn State Research Foundation Surfactant prevention of lung complications from cancer chemotherapy
SI1458360T1 (sl) * 2001-12-19 2011-08-31 Novartis Ag Pulmonalno dajanje aminoglikozidov
US20040023935A1 (en) * 2002-08-02 2004-02-05 Dey, L.P. Inhalation compositions, methods of use thereof, and process for preparation of same
US20040109826A1 (en) * 2002-12-06 2004-06-10 Dey, L.P. Stabilized albuterol compositions and method of preparation thereof
EP1638567B1 (en) 2003-06-16 2012-02-29 Nycomed GmbH Composition comprising a pulmonary surfactant and sildenafil for the treatment of lung diseases
EP1670482B2 (en) * 2003-09-16 2022-06-29 Covis Pharma B.V. Use of ciclesonide for the treatment of respiratory diseases
US7464012B2 (en) * 2004-12-10 2008-12-09 L'air Liquide, Societe Anonyme A Directoire Et Conseil De Surveillance Pour L'etude Et L'exploitation Des Procedes Georges Claude Simplified process simulator
US7582312B2 (en) * 2004-11-15 2009-09-01 Discovery Laboratories, Inc. Methods to produce lung surfactant formulations via lyophilization and formulations and uses thereof
WO2006074296A1 (en) 2005-01-06 2006-07-13 Discovery Laboratories, Inc. Surfactant treatment regimen for treating or preventing bronchopulmonary dysplasia
KR100891595B1 (ko) 2005-02-28 2009-04-03 주식회사 케이티앤지 혈액 단백질의 삼출을 감소시키는 조성물
WO2008036293A1 (en) * 2006-09-19 2008-03-27 Discovery Laboratories, Inc. Pulmonary surfactant formulations and methods for promoting mucus clearance
EP2022798A1 (en) * 2007-08-09 2009-02-11 CHIESI FARMACEUTICI S.p.A. Synthetic pulmonary surfactant peptides
WO2012077127A1 (en) * 2010-12-10 2012-06-14 Indian Institute Of Technology, Bombay A protein free surfactant composition for pulmonary diseases and a process for preparing the same
WO2013188016A2 (en) 2012-05-04 2013-12-19 Discovery Laboratories, Inc. Surfactant therapy for exposure to ionizing radiation
CN106310280A (zh) * 2016-08-18 2017-01-11 滨州医学院 地瑞那韦增强糖皮质激素抗炎作用的医药新用途
AU2017384467B2 (en) * 2016-12-22 2023-10-19 Chiesi Farmaceutici S.P.A. A therapeutic combination comprising a pulmonary surfactant and a steroid for the treatment of evolving BPD

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4944941A (en) * 1987-08-07 1990-07-31 Genentech, Inc. Methods and compositions for the treatment of lung conditions
US5006343A (en) * 1988-12-29 1991-04-09 Benson Bradley J Pulmonary administration of pharmaceutically active substances

Also Published As

Publication number Publication date
JPH10506119A (ja) 1998-06-16
US5891844A (en) 1999-04-06
DK0783314T3 (da) 2003-12-01
JP4425991B2 (ja) 2010-03-03
SK40197A3 (en) 1998-02-04
WO1996009831A2 (de) 1996-04-04
ATE241372T1 (de) 2003-06-15
HU226958B1 (en) 2010-03-29
RU2157222C2 (ru) 2000-10-10
AU3742895A (en) 1996-04-19
CN1163571A (zh) 1997-10-29
PL187496B1 (pl) 2004-07-30
MX9702303A (es) 1997-06-28
NO971403L (no) 1997-04-17
CA2201377A1 (en) 1996-04-04
NZ294587A (en) 1998-07-28
EE9700084A (et) 1997-10-15
PT783314E (pt) 2003-10-31
CA2201377C (en) 2008-07-29
CZ94097A3 (en) 1997-09-17
ES2201120T3 (es) 2004-03-16
HUT77931A (hu) 1998-11-30
EE03422B1 (et) 2001-06-15
BG101441A (en) 1997-09-30
DE59510705D1 (de) 2003-07-03
WO1996009831A3 (de) 1996-05-23
HK1003869A1 (en) 1998-11-13
KR970706006A (ko) 1997-11-03
FI118886B (fi) 2008-04-30
EP0783314A2 (de) 1997-07-16
FI971277A (fi) 1997-05-27
EP0783314B1 (de) 2003-05-28
NO971403D0 (no) 1997-03-25
BG62556B1 (bg) 2000-02-29
PL319608A1 (en) 1997-08-18
FI971277A0 (fi) 1997-03-26
CZ292846B6 (cs) 2003-12-17
NO313405B1 (no) 2002-09-30
CN1100542C (zh) 2003-02-05
KR100365030B1 (ko) 2003-03-10
AU705099B2 (en) 1999-05-13
DE4434629C1 (de) 1996-06-27
SK284446B6 (sk) 2005-04-01

Similar Documents

Publication Publication Date Title
UA43378C2 (uk) Композиція для лікування респіраторного дистрес-синдрому новонароджених та респіраторного дистрес-синдрому дорослих
MX9700538A (es) Uso de droloxifeno y sus sales farmaceuticamente aceptables en la preparacion de remedios para las enfermedades cardiovasculares.
EP0870786A4 (en) DIENE RUBBER, PREPARATION PROCESS AND COMPOSITION CONTAINING THE SAME
NL300433I2 (en) Methods and compositions for the treatment of glomerulonephritis.
IL114294A0 (en) Sterol derivatives
DE69202207D1 (de) Verfahren zur Herstellung von 1-Chlor-1,1,3,3,3-Pentafluorpropan und von 1,1,1,3,3,3-Hexafluorpropan.
AU2533697A (en) Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders
EP0690457A3 (en) Polyaniline solution, objects coated therewith and method for producing the same
MX9704030A (es) 1,1-dioxidos de 2-heterocicliloxi y tiometil-1,2,5-tiadiazolidin-3-ona y composiciones y metodo de uso de los mismos.
EP0247167A4 (en) HYDROXY AND AMINOTHIAZOLYL-BENZODIAZINONE COMPOUNDS, CARDIOTONIC COMPOSITIONS CONTAINING THEM AND THEIR USES.
AU3636695A (en) Method, compositions, and apparatus for treating and preventing respiratory viral infections
AU1725188A (en) Pyridooxazinone-pyridone compounds, cardiotonic compositions including the same, and their uses
AU3192084A (en) Pharmaceutical compositions of benzothiophene derivatives
TR199901772T2 (uk)
EP0667870A4 (en) COMPOSITIONS AND METHODS FOR MODIFYING THE REGULATORY ACTIVITY OF TGF-BETA.
MX9602445A (es) Pigmentos dorados.
BG102250A (en) The use of marigold-extracted glycosides for the treatment of psoriasis
EP0777473A4 (en) PREPARATIONS AND METHOD FOR CONTROLLING SMOKING
MY128260A (en) Cyclopentane-and-pentene-b-amino acids
MX9704034A (es) Derivados y composiciones de 1,1-dioxido de 2-arilcarboniloximetil-1,2,5-tiadiazolidin-3-ona substituido y metodo de uso.
ZA978640B (en) Use of 1-hydroxy-2-pyridones for the treatment of saborrheic dermatitis.
DE69407057D1 (de) 1,3.5 (10) - estratriene derivate mit oraler wirkung
ZA973289B (en) Steroids, their use as medicaments, their preparation process, the intermediates of this process and the compositions containing them.
IL73825A0 (en) Compositions containing an n,n'-alkylenediamide or and amidoalkylimidazole derivative and process for preparing the same
EP0852503A4 (en) AGENTS FOR THE TREATMENT OF DIARRHÖ, THEIR USE AND PRODUCTION